“…Six were conducted in Asia, seven each in Europe and North America, and one included people from multiple continents [ 48 ]. Twelve cohorts included people with CAP [ [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] ], one with HAP [ 60 ], none with COVID-19 pneumonia, one with AP [ [61] , [62] , [63] ], three with HCAP or NHCAP [ [64] , [65] , [66] ], five described “pneumonia” only, or included mixed types of pneumonias [ 47 , [67] , [68] , [69] , [70] ]. One of these cohorts published data on two sub-cohorts, one of people with CAP, the other with pneumonia and chronic kidney disease [ 70 ].…”